Mining anticoagulant peptides from Poecilobdella manillensis by peptidomics analysis

doi:10.1007/s13659-025-00573-0

Abstract

Abstract: Thrombosis triggers various severe diseases, while antithrombotic drugs carry bleeding risks, making the development of novel natural anticoagulants a subject of widespread attention. Poecilobdella manillensis, a prevalent medicinal leech, exhibits remarkable anticoagulant and antithrombotic activities. However, the material basis underlying its anticoagulant effects remains insufficiently investigated. This study aims to mine anticoagulant peptides from P. manillensis by peptidomics analysis, elucidate the material basis of its anticoagulant activity, and provide candidate molecules for developing novel natural anticoagulant drugs. Proteins extracted from P. manillensis were enzymatically digested and fractionated using DEAE-52 and CN columns. The resulting peptide components were analyzed by UPLC-Q-Orbitrap HRMS, and peptide sequences were matched against proteomic databases using Proteome Discoverer. Anticoagulant peptides were predicted using the BIOPEP-UWM database and PeptideRanker server, followed by in vitro and in vivo activity validation. Results showed that the hydrolysate consisted predominantly of low-molecular-weight peptides. 1533 peptides with Mw < 3000 Da (length < 20 amino acids) were identified from the PM-A2 and PM-A3 fractions, accounting for 40.76% of the total. Four peptides selected through predictive screening demonstrated anticoagulant and antithrombotic activities in vitro. Among them, LE-11 significantly prolonged both APTT and TT (P < 0.0001). Furthermore, LE-11 effectively alleviated carrageenan-induced thrombosis in mice, outperforming the heparin control at the mid-concentration (20 mg/kg). In this study, the highly active anticoagulant peptide LE-11 was identified from P. manillensis through peptidomic analysis. These findings establish a solid foundation for developing anticoagulant drugs from this source and provide critical scientific support for its clinical application in treating thrombotic diseases.

Key words: Poecilobdella manillensis, Peptidomics analysis, Medicinal leech, Anticoagulant peptides, Hirudo

摘要： Thrombosis triggers various severe diseases, while antithrombotic drugs carry bleeding risks, making the development of novel natural anticoagulants a subject of widespread attention. Poecilobdella manillensis, a prevalent medicinal leech, exhibits remarkable anticoagulant and antithrombotic activities. However, the material basis underlying its anticoagulant effects remains insufficiently investigated. This study aims to mine anticoagulant peptides from P. manillensis by peptidomics analysis, elucidate the material basis of its anticoagulant activity, and provide candidate molecules for developing novel natural anticoagulant drugs. Proteins extracted from P. manillensis were enzymatically digested and fractionated using DEAE-52 and CN columns. The resulting peptide components were analyzed by UPLC-Q-Orbitrap HRMS, and peptide sequences were matched against proteomic databases using Proteome Discoverer. Anticoagulant peptides were predicted using the BIOPEP-UWM database and PeptideRanker server, followed by in vitro and in vivo activity validation. Results showed that the hydrolysate consisted predominantly of low-molecular-weight peptides. 1533 peptides with Mw < 3000 Da (length < 20 amino acids) were identified from the PM-A2 and PM-A3 fractions, accounting for 40.76% of the total. Four peptides selected through predictive screening demonstrated anticoagulant and antithrombotic activities in vitro. Among them, LE-11 significantly prolonged both APTT and TT (P < 0.0001). Furthermore, LE-11 effectively alleviated carrageenan-induced thrombosis in mice, outperforming the heparin control at the mid-concentration (20 mg/kg). In this study, the highly active anticoagulant peptide LE-11 was identified from P. manillensis through peptidomic analysis. These findings establish a solid foundation for developing anticoagulant drugs from this source and provide critical scientific support for its clinical application in treating thrombotic diseases.

关键词: Poecilobdella manillensis, Peptidomics analysis, Medicinal leech, Anticoagulant peptides, Hirudo

Han-xue Zheng, Xiao-li Deng, Teng-teng Li, Guo-hua Xia, Huan Yang, Jiang-song Peng, Yu-ping Shen. Mining anticoagulant peptides from Poecilobdella manillensis by peptidomics analysis[J]. Natural Products and Bioprospecting, 2026, 16(2): 24-24.

References

[1] Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359(9):938-49. https://doi.org/10.1056/NEJMra0801082.
[2] Weisel JW. Enigmas of blood clot elasticity. Science. 2008;320(5875):456-7. https://doi.org/10.1126/science.1154210.
[3] Chaudhari K, Hamad B, Syed BA. Antithrombotic drugs market. Nat Rev Drug Discov. 2014;13(8):571-2. https://doi.org/10.1038/nrd4365.
[4] Khalid M, Chen Y, Zhou S, Asmamaw D, Mwangi J, Chen Q, et al. The derivatives of hirudin-like peptides from the Poecilobdella manillensis exhibit antithrombotic and anti-ischemic stroke effects. Int J Biol Macromol. 2025;307:141950. https://doi.org/10.1016/j.ijbiomac.2025.141950.
[5] Cao D, Amabile N, Chiarito M, Lee VT, Angiolillo DJ, Capodanno D, et al. Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding. Eur Heart J. 2023;44(20):1780-94. https://doi.org/10.1093/eurheartj/ehad119.
[6] Tang X, Liu X, Mikaye MS, Zhao H, Zhang Y. Traditional Chinese medicine in the treatment of high incidence diseases in cold areas: the thrombotic diseases. Frigid Zone Med. 2021;1(1):23-44. https://doi.org/10.2478/fzm-2021-0005.
[7] Zheng Y, Lu BB, Yang YY, Jiao ZQ, Chen LQ, Yu PT, et al. Rapid identification of medicinal leech by species-specific polymerase chain reaction technology. Pharmacogn Mag. 2019;15(63):410. https://doi.org/10.4103/pm.pm_596_18.
[8] Zhang YJ, Yang R, Wang LW, Li Y, Han J, Yang YY, et al. Purification and characterization of a novel thermostable anticoagulant protein from medicinal leech Whitmania pigra Whitman. J Ethnopharmacol. 2022;288:114990. https://doi.org/10.1016/j.jep.2022.114990.
[9] Peng JS, Li Y, Deng XL, Lu MY, Yang CB, Shen YP, et al. Loop-mediated isothermal amplification for on-site visual identification of Leech species. Food Anal Method. 2024;17(4):618-27. https://doi.org/10.1007/s12161-024-02597-7.
[10] Montinari MR, Minelli S. From ancient leech to direct thrombin inhibitors and beyond: new from old. Biomed Pharmacother. 2022;149:112878. https://doi.org/10.1016/j.biopha.2022.112878.
[11] Meng FM, Liu ZC, Sun JW, Kong DJ, Wang YX, Tong XR, et al. Insights into gut microbiota communities of Poecilobdella manillensis, a prevalent Asian medicinal leech. J Appl Microbiol. 2022;133(3):1402-13. https://doi.org/10.1111/jam.15514.
[12] Wang CM, Chen MR, Lu XY, Yang S, Yang M, Fang YQ, et al. Isolation and characterization of Poeciguamerin, a peptide with dual analgesic and anti-thrombotic activity from the Poecilobdella manillensis leech. Int J Mol Sci. 2023;24(13):11097. https://doi.org/10.3390/ijms241311097.
[13] Li Y, Guo XH, Lei Y, Hou JW, Xie HL, Yuan RJ. Peptide identification and molecular characterization of enzymatic hydrolysates from Poecilobdella manillensis based on UPLC-Q-Exactive-MS. Drug Evaluation Research. 2022;45(1):48-59.
[14] Balakrishnan A, Mishra SK, Sharma K, Gaglani C, Georrge JJ. Intersecting Peptidomics and Bioactive Peptides in Drug Therapeutics. Curr Bioinf. 2025;20(2):103-19. https://doi.org/10.2174/0115748936351054241010091822.
[15] Minkiewicz P, Iwaniak A, Darewicz M. Contemporary bioinformatics and cheminformatics support for food peptidomics. Curr Opin Food Sci. 2024;56:101125. https://doi.org/10.1016/j.cofs.2024.101125.
[16] Zhou MZ, Li W, Zheng L, Zhao MM. Screening myocardial protective peptides from bovine myocardium hydrolysates: a peptidomics-activity guided strategy integrating fractionated extraction, multivariate analysis and random forest. J Agric Food Chem. 2025;73(38):24187-99. https://doi.org/10.1021/acs.jafc.5c08886.
[17] Schrader M, Schulz-Knappe P. Peptidomics technologies for human body fluids. Trends Biotechnol. 2001;19(10). https://doi.org/10.1016/s0167-7799(01)00010-5
[18] Camargo ACM, Ianzer D, Guerreiro JR, Serrano SMT. Bradykinin-potentiating peptides: beyond captopril. Toxicon. 2012;59(4):516-23. https://doi.org/10.1016/j.toxicon.2011.07.013.
[19] Furman BL. The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent. Toxicon. 2012;59(4):464-71. https://doi.org/10.1016/j.toxicon.2010.12.016.
[20] Abelin JG, Cox AL. Innovations toward immunopeptidomics. Mol Cell Proteomics. 2024;23(9):100823. https://doi.org/10.1016/j.mcpro.2024.100823.
[21] Hu LJ, Liu N, Li YC, Zhang QC, Cui XB, Shan CX, et al. A novel strategy to identify the species-specific peptide biomarkers in Pheretima aspergillum (E. Perrier) based on enzymatic digestion followed by LC-MS/MS methods. J Pharm Biomed Anal. 2023;229:115372. https://doi.org/10.1016/j.jpba.2023.115372.
[22] Martini S, Solieri L, Tagliazucchi D. Peptidomics: new trends in food science. Curr Opin Food Sci. 2021;39:51-9. https://doi.org/10.1016/j.cofs.2020.12.016.
[23] Cheng RM, Tang XP, Long AL, Mwangi J, Lai R, Sun RP, et al. Purification and characterization of a novel anti-coagulant from the leech Hirudinaria manillensis. Zool Res. 2019;40(3):205-10. https://doi.org/10.24272/j.issn.2095-8137.2019.037.
[24] Zheng XB, Li J, Chen ZW, Liu YM, Chen KL. Purification and characterization of an anticoagulant oligopeptide from Whitmania pigra Whitman. Pharmacogn Mag. 2015;11(43):444. https://doi.org/10.4103/0973-1296.160446.
[25] Rojas-Ronquillo R, Cruz-Guerrero A, Flores-Nájera A, Rodríguez-Serrano G, Gómez-Ruiz L, Reyes-Grajeda JP, et al. Antithrombotic and angiotensin-converting enzyme inhibitory properties of peptides released from bovine casein by Lactobacillus casei Shirota. Int Dairy J. 2012;26(2):147-54. https://doi.org/10.1016/j.idairyj.2012.05.002.
[26] Zhang SB. In vitro antithrombotic activities of peanut protein hydrolysates. Food Chem. 2016;202:1-8. https://doi.org/10.1016/j.foodchem.2016.01.108.
[27] Yu G, Wang F, Zhang B, Fan J. In vitro inhibition of platelet aggregation by peptides derived from oat (Avena sativa L.), highland barley (Hordeum vulgare Linn. var. nudum Hook. f.), and buckwheat (Fagopyrum esculentum Moench) proteins. Food Chem. 2016;194:577-86. https://doi.org/10.1016/j.foodchem.2015.08.058.
[28] Li A, Guo Q, Kim C, Hu W, Ye F. Integrin αIIb tail distal of GFFKR participates in inside-out αIIbβ3 activation. J Thromb Haemost. 2014;12(7):1145-55. https://doi.org/10.1111/jth.12610.
[29] Ashmarin IP, Karazeeva EP, Lyapina LA, Samonina GE. The simplest proline-containing peptides PG, GP, PGP, and GPGG: regulatory activity and possible sources of biosynthesis. Biochemistry (Mosc). 1998;63(2):119-24.
[30] Lee KA, Kim SH. SSGE and DEE, new peptides isolated from a soy protein hydrolysate that inhibit platelet aggregation. Food Chem. 2005;90(3):389-93. https://doi.org/10.1016/j.foodchem.2004.04.010.
[31] Maruyama S, Nonaka I, Tanaka H. Inhibitory effects of enzymatic hydrolysates of collagen and collagen-related synthetic peptides on fibrinogen/thrombin clotting. Biochim Biophys Acta. 1993;1164(2):215-8. https://doi.org/10.1016/0167-4838(93)90250-U.
[32] Mazoyer E, Lévy-Toledano S, Rendu F, Hermant L, Lu H, Fiat A, et al. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction. Eur J Biochem. 1990;194(1):43-9. https://doi.org/10.1111/j.1432-1033.1990.tb19424.x.